Searched for
TRUMP PHARMA TARIFFS
Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- Why is market falling today? 7 triggers behind 800-point Sensex fall, Rs 4 lakh crore wealth wipeoutIndian stock markets experienced a decline on Wednesday as tensions in the Middle East escalated. Crude oil prices surged above $92 a barre...
- India's gem and jewellery exports rise 26.5% in June, shining at $2.21 billionIndia's gem and jewellery exports saw a significant rebound in June, increasing by 26.5 percent. Lower international gold prices and improv...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...
- Hikal commissions cGMP pilot plant in Pune to strengthen pharmaceutical developmentHikal has commissioned an enhanced cGMP pilot plant at its Pune campus to strengthen its integrated capabilities for pharmaceutical develop...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities posted their steepest single-day decline since March as rising crude prices, renewed Middle East tensions and weak global c...
- Additional US tariffs on Indian goods since April 2025: Here’s the full timelineThe United States imposed a series of tariffs on Indian goods starting April 2025. These duties varied, with some being reciprocal and othe...
- Just like bad medicine...Trump tariff pricks again; India not seen badly hit by US’ latest salvoUS President Trump’s 100% tariff on pharmaceutical products targets only branded and patented drugs, leaving India’s generic exports largel...
- Big US pharma stocks rise as Street reacts to Trump's tariff on drugsPresident Trump announced new 100 percent import taxes on branded pharmaceuticals. These tariffs begin October 1. Companies building US man...
- Sun Pharma, Wockhardt & other pharma stocks crack up to 9% as Trump announces 100% tariff on imported patented drugsPharma stocks declined following Donald Trump's tariff announcement. Wockhardt experienced the biggest drop. Sun Pharma also hit a 52-week ...
- Trump delivers another bitter tariff pill. Who’s set to bite the dust?A new tariff announced by President Trump will impose a 100% levy on patented pharmaceuticals entering the U.S. from October 1, 2025, unles...
- Trump tariff hunt eyes India's last stock market refuge but it won't be an easy killIndian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite India's strong p...
- Now Pharma Inc looks for cure as Trump delivers dose of anxietyUS President Trump has announced that new tariffs on pharmaceuticals will be introduced soon, creating uncertainty for India's drug makers....
- No chill, just pills! Pharma stocks slide up to 8% as Trump does yes-no-yes on tariffShares of Indian pharma companies, including Aurobindo Pharma, Laurus Labs, IPCA Labs, and Lupin, fell up to 8% after U.S. President Donald...
Load More
